Amnestix Inc., Sygnis Pharma deal

Sygnis acquired Amnestix for about €4 million ($5.6 million) in cash

Read the full 117 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE